Ovarian cancer plaintiff to receive $55 million payout
Johnson & Johnson must pay $55 million to a woman who said the company’s talcum powder caused her to develop ovarian cancer. A federal jury awarded the plaintiff $5 million in compensatory as well as $50 million in punitive damages.
The verdict marks the second straight courtroom loss for the pharmaceutical giant. Johnson & Johnson was ordered to pay another $72 million to the family of a victim who succumbed to ovarian cancer after using their talcum powder. The company plans to appeal both rulings.
There are other 1,200 lawsuits accusing Johnson & Johnson of failing to warn their customers of the potential dangers associated with talc.
The company stands by its product, claiming 30+ years of research shows talcum powder is safe. While the American Cancer Society claims its not clear that there’s a connection between talcum powder and cancer, the International Agency for Research on Cancer (part of the World Health Organization) lists the substance as a possible carcinogen.
Unlike most health-related products, talcum powder is considered to be cosmetic and therefore is not under the review of the Food and Drug Administration. Proper labels, however, are required of all substances that are potentially harmful to users.
Whether or not health organizations and researchers agree about the safety of talcum powder is not for Johnson & Johnson to decide. They owe it to their customers, to be honest about the potential hazards associated with the product. A simple addition to their labels cautioning users of the risks of using talc on female genitalia could save countless lives.
Talcum Powder Ovarian Cancer Lawsuits
The Law Offices of Richard J. Serpe, PC are currently investigating cases related to talcum and baby powder use on the genitals and ovarian cancer. If you or your loved one would like to set up a free consultation to discuss your situation, contact our office today.